Skip to main content

Blocking Memories to Treat Alcoholism

Targeting a molecular pathway involved with learning and memory helps rats with a taste for booze wean themselves off of the sauce.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

FLICKR, KEN30684The key to preventing relapse in recovering alcoholics may be to block memories associated with the pleasurable effects of drinking, according to a new study in rats. Neuroscientists at the University of California, San Francisco (UCSF), found that administering the drug rapamycin to block the mTORC1 pathway, which is associated with learning and memory, helped reduce alcoholic relapse in rats that had developed a preference for alcohol. The results were published Sunday (June 23) in Nature Neuroscience.

The mTORC1 pathway is versatile, spawning proteins that regulate a variety of physiological functions in several species, from autophagy and the growth and proliferation of stem cells to mitochondrial metabolism and memory recall. Rapamycin, a powerful antifungal, disrupts the mTORC1 pathway, and research has already shown the drug’s potential in treating drug addiction and post-traumatic stress disorder byu targeting the pathway. “It’s really excellent,” Charles O’Brien, director of the Center for Studies of Addiction at the University of Pennsylvania in Philadelphia, told Nature. “Fundamentally, addiction is a memory, and [the authors] are going straight at what is actually going on in the brain.”

UCSF neuroscientist Dorit Ron, who led the team of researchers, told Nature that while the scientists weren’t sure which specific memory they ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo